The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Jun. 17, 2014
Applicant:

Oncoarendi Therapeutics Sp. Z.o.o., Warsaw, PL;

Inventors:

Stanislaw Wieslaw Pikul, Jaslo, PL;

Wieslaw Marek Cholody, Frederick, MD (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 233/42 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); A61K 31/4178 (2006.01); A61K 45/06 (2006.01); C07C 247/06 (2006.01); C07D 401/14 (2006.01); A61K 31/454 (2006.01); C07D 409/14 (2006.01); C07D 403/14 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07D 405/14 (2013.01); A61K 31/4178 (2013.01); A61K 45/06 (2013.01); C07C 247/06 (2013.01); C07D 401/14 (2013.01); A61K 31/454 (2013.01); C07D 409/14 (2013.01); C07D 403/14 (2013.01); A61K 31/506 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01);
Abstract

The invention provides novel, water-soluble 2-aminoimidazoline derivatives having general Formula (I) as well as some precursors of Formula (I), which are very potent inducers of G2/M cell cycle arrest. In treated tumor cells, compounds of Formula (I) give gene expression profile distinct from known antimitotic agents. The invention also provides methods for preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirably high levels of cell proliferation. The compounds of the invention are also expected to have utility as research tools.


Find Patent Forward Citations

Loading…